317 related articles for article (PubMed ID: 15540922)
1. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
2. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
Zhang RX; Dougherty DV; Rosenblum ML
Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
[TBL] [Abstract][Full Text] [Related]
3. Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
Horvath Z; Höchtl T; Bauer W; Fritzer-Szekeres M; Elford HL; Szekeres T; Tihan T
Cancer Chemother Pharmacol; 2004 Aug; 54(2):139-45. PubMed ID: 15133626
[TBL] [Abstract][Full Text] [Related]
4. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
5. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
[TBL] [Abstract][Full Text] [Related]
6. Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations.
Bodell WJ
Anticancer Res; 2000; 20(5A):3099-103. PubMed ID: 11062728
[TBL] [Abstract][Full Text] [Related]
7. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ
J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the mechanism of ACNU resistance in sublines of rat C6 glioma and 9L gliosarcoma in vitro].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Kato A; Mogami H; Sakamoto Y
No Shinkei Geka; 1986 Oct; 14(11):1299-304. PubMed ID: 3468375
[TBL] [Abstract][Full Text] [Related]
9. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells.
Smith MT; Evans CG; Doane-Setzer P; Castro VM; Tahir MK; Mannervik B
Cancer Res; 1989 May; 49(10):2621-5. PubMed ID: 2713846
[TBL] [Abstract][Full Text] [Related]
10. The role of minocycline in the treatment of intracranial 9L glioma.
Weingart JD; Sipos EP; Brem H
J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527
[TBL] [Abstract][Full Text] [Related]
11. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Hank NC; Shapiro JR; Scheck AC
BMC Cancer; 2006 Jan; 6():2. PubMed ID: 16393339
[TBL] [Abstract][Full Text] [Related]
12. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma.
Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD
Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484
[TBL] [Abstract][Full Text] [Related]
13. Effect of caffeine on cytotoxicity and sister chromatid exchange induction in sensitive and resistant rat brain tumor cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Aida T; Bodell WJ
Cancer Res; 1987 Oct; 47(19):5052-8. PubMed ID: 3621190
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G
Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315
[TBL] [Abstract][Full Text] [Related]
15. Increased tumor cures using combined radiosurgery and BCNU in the treatment of 9l glioma in the rat brain.
Khil MS; Kolozsvary A; Apple M; Kim JH
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):511-6. PubMed ID: 10802380
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer.
Chae GS; Lee JS; Kim SH; Seo KS; Kim MS; Lee HB; Khang G
Int J Pharm; 2005 Sep; 301(1-2):6-14. PubMed ID: 16024190
[TBL] [Abstract][Full Text] [Related]
17. Reduced level of DNA cross-links and sister chromatid exchanges in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant rat brain tumor cells.
Bodell WJ; Rupniak HT; Rasmussen J; Morgan WF; Rosenblum ML
Cancer Res; 1984 Sep; 44(9):3763-7. PubMed ID: 6744295
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells.
Yan YR; Xie Q; Li F; Zhang Y; Ma JW; Xie SM; Li HY; Zhong XY
Neuropathology; 2014 Apr; 34(2):128-34. PubMed ID: 24112388
[TBL] [Abstract][Full Text] [Related]
19. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.
Tamargo RJ; Myseros JS; Epstein JI; Yang MB; Chasin M; Brem H
Cancer Res; 1993 Jan; 53(2):329-33. PubMed ID: 8417826
[TBL] [Abstract][Full Text] [Related]
20. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]